In a report released yesterday, Stephen Macleod from BMO Capital reiterated a Buy rating on Jamieson Wellness Inc (JWEL – Research Report), with a price target of C$41.00.
Stephen Macleod has given his Buy rating due to a combination of factors that highlight Jamieson Wellness Inc’s strong growth potential. The company is well-positioned to achieve its long-term revenue target of over $1 billion, driven primarily by its Jamieson Brands segment across various geographies. This growth is supported by favorable market trends such as an aging population, rising incomes, and an increased focus on health and wellness.
In particular, the U.S. and China markets offer significant growth opportunities, with strategies in place to leverage e-commerce and product innovation to boost sales. Additionally, Jamieson’s valuation appears attractive, trading below the peer average, which further supports the Buy recommendation. The company’s ability to expand its market leadership in Canada and capitalize on international opportunities underpins its robust growth outlook.
In another report released yesterday, RBC Capital also maintained a Buy rating on the stock with a C$40.00 price target.
JWEL’s price has also changed moderately for the past six months – from C$34.460 to C$29.460, which is a -14.51% drop .